Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

26studies shown

Showing 1-12 of 26

Other study type icon

RecruitingISRCTN83479057

A clinical study to investigate whether third-line treatments work better as a second-line treatment for people diagnosed with schizophrenia

The registry lists this study as recruiting. Study locations are listed in Australia, in the United Kingdom, in Austria, ...

In Australia

SchizophreniaOtherFrom 18 Years to 70 Years

Countries: Australia, United Kingdom, Austria, ...
Sponsor: University Medical Center Utrecht
Condition: Schizophrenia

Drug study icon

RecruitingNCT05408247

A Controlled study of N-acetylcysteine for the Management of Addiction

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia

AddictionDrugFrom 18 Years to 70 Years

Countries: Australia
Sponsor: University of Sydney
Condition: Addiction

Behavioral study icon

RecruitingNCT06793397

A Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in the United Kingdom, ...

In Australia

DepressionBehavioralFrom 18 Years to 85 Years

Countries: United States, Australia, United Kingdom, ...
Sponsor: Cybin IRL Limited
Condition: Depression

Drug study icon

RecruitingNCT07412756

Brenipatide in adults with Major Depressive Disorder

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In Australia

DepressionDrugFrom 18 Years to 75 Years

Countries: United States, Australia, Canada, ...
Sponsor: Eli Lilly and Company
Condition: Depression

Drug study icon

RecruitingNCT06524830

VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In Australia

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Australia, Canada, ...
Sponsor: atai Therapeutics, Inc.
Condition: Depression

Drug study icon

RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

In Australia

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Australia, France, ...
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

Drug study icon

RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in New Zealand, ...

In Australia

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Australia, New Zealand, ...
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

Drug study icon

RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In Australia

DepressionDrugOver 18 Years

Countries: United States, Australia, Canada, ...
Sponsor: Neurocrine Biosciences
Condition: Depression

Behavioral study icon

RecruitingNCT05982158

Avatar-mediated Therapy Versus Cognitive Behavioural Therapy for Persisting Experiences of Hearing Voices

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaBehavioralOver 18 Years

Countries: Australia
Sponsor: Swinburne University of Technology
Condition: Schizophrenia

Drug study icon

RecruitingNCT04113993

Bazedoxifene -Treatment for Women With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: Australia
Sponsor: The Alfred
Condition: Schizophrenia

Drug study icon

RecruitingACTRN12620000703909

CADET candesartan study for depression in bipolarity: a study

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia

Bipolarity, DepressionDrugOver 18 Years

Countries: Australia
Sponsor: Deakin University
Condition: Bipolarity, Depression

Drug study icon

RecruitingNCT06278779

Comparative Effectiveness Study of Two Forms of Ketamine for Treatment-resistant Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Australia

DepressionDrugOver 18 Years

Countries: Australia
Sponsor: The George Institute
Condition: Depression

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.